Serum Homocysteine Level Is a Predictor of Relapse and Prognosis in Patients With First-Attack Neuromyelitis Optica Spectrum Disorders

Background: Many patients with neuromyelitis optica spectrum disorders (NMOSD) experience the adverse consequences of relapse and disability aggravation. Thus, it is necessary to identify sensitive and reliable biomarkers for early prognosis. This study investigated whether serum homocysteine (Hcy)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinwei, Li, Yanfei, Zhou, Yongyan, Zhao, Yi, Xie, Haojie, Duan, Ranran, Yao, Yaobing, Gong, Zhe, Teng, Junfang, Jia, Yanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187771/
https://www.ncbi.nlm.nih.gov/pubmed/34122309
http://dx.doi.org/10.3389/fneur.2021.667651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187771/
https://www.ncbi.nlm.nih.gov/pubmed/34122309
http://dx.doi.org/10.3389/fneur.2021.667651

Ejemplares similares